April 23, 2024 21:06 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Rajnath Singh visits Siachen, carries out assessment of security situation | Government employee shot dead in targeted attack in Kashmir's Rajouri | 'Congress will take away your homes, jewels': PM Modi ups his attack amid row | Centre orders sampling test of spices from Everest, MDH after ban in Hong Kong, Singapore | 'Illegal, I challenge it': Mamata Banerjee on Calcutta HC cancelling 24,000 jobs in SSC scam probe
Glenmark's shares surge after getting government approval for Covid-19 drug

Glenmark's shares surge after getting government approval for Covid-19 drug

Mumbai/IBNS: The shares of Glenmark Pharmaceuticals on Monday surged days after getting an approval from the Drugs Controller General of India (DCGI) to market and manufacture antiviral drug Favipiravir, to be sold under the brand name FabiFlu, for the treatment of Covid-19 patients having mild to moderate symptoms.